Tomohiro Murata

1.1k total citations
74 papers, 693 citations indexed

About

Tomohiro Murata is a scholar working on Surgery, Nephrology and Molecular Biology. According to data from OpenAlex, Tomohiro Murata has authored 74 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 21 papers in Nephrology and 17 papers in Molecular Biology. Recurrent topics in Tomohiro Murata's work include Renal Diseases and Glomerulopathies (11 papers), Dialysis and Renal Disease Management (7 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). Tomohiro Murata is often cited by papers focused on Renal Diseases and Glomerulopathies (11 papers), Dialysis and Renal Disease Management (7 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). Tomohiro Murata collaborates with scholars based in Japan, Sweden and United Kingdom. Tomohiro Murata's co-authors include Shinsuke Nomura, Eiji Ishikawa, Masaaki Ito, Hideo Tohgi, Hiroshi Matsuo, Takashi Abe, Kan Katayama, Ken Yamazaki, Sei Sasaki and Shigeaki Nonoyama and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of the American Society of Nephrology.

In The Last Decade

Tomohiro Murata

69 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomohiro Murata Japan 12 256 104 100 92 79 74 693
Hae-Rahn Bae South Korea 15 343 1.3× 106 1.0× 42 0.4× 99 1.1× 75 0.9× 31 763
Begoña Campos United States 21 508 2.0× 201 1.9× 108 1.1× 145 1.6× 98 1.2× 48 1.2k
Mariana Kiomy Osako Japan 20 421 1.6× 171 1.6× 125 1.3× 106 1.2× 88 1.1× 40 1.2k
J Rabczyński Poland 16 169 0.7× 235 2.3× 45 0.5× 107 1.2× 96 1.2× 92 838
Yoshifusa Abe Japan 13 380 1.5× 82 0.8× 174 1.7× 60 0.7× 60 0.8× 50 778
Zhang Ping France 16 507 2.0× 53 0.5× 63 0.6× 117 1.3× 45 0.6× 23 935
Purvi Mehrotra United States 17 195 0.8× 62 0.6× 158 1.6× 68 0.7× 49 0.6× 21 734
Limary M. Cancel United States 19 406 1.6× 210 2.0× 103 1.0× 190 2.1× 137 1.7× 38 1.4k
Jianping Peng China 20 569 2.2× 288 2.8× 127 1.3× 95 1.0× 122 1.5× 77 1.4k
Sean M. Forsythe United States 13 480 1.9× 125 1.2× 118 1.2× 244 2.7× 108 1.4× 17 1.1k

Countries citing papers authored by Tomohiro Murata

Since Specialization
Citations

This map shows the geographic impact of Tomohiro Murata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Murata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Murata more than expected).

Fields of papers citing papers by Tomohiro Murata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiro Murata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Murata. The network helps show where Tomohiro Murata may publish in the future.

Co-authorship network of co-authors of Tomohiro Murata

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiro Murata. A scholar is included among the top collaborators of Tomohiro Murata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiro Murata. Tomohiro Murata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oda, Keiko, Kan Katayama, Liqing Zang, et al.. (2024). The Protective Role of KANK1 in Podocyte Injury. International Journal of Molecular Sciences. 25(11). 5808–5808. 1 indexed citations
2.
Oda, Keiko, Tomohiro Murata, Masahiro Yamawaki, et al.. (2024). A case of acute kidney injury and Fanconi syndrome while taking multiple supplements, including Red Yeast Rice Cholesterol Help®. CEN Case Reports. 14(1). 47–51. 7 indexed citations
3.
Katayama, Kan, Masahiro Yamawaki, Keiko Oda, et al.. (2024). Nephrotic syndrome with acute kidney injury due to combination therapy of immune checkpoint inhibitors: a case report and review of the literature. BMC Nephrology. 25(1). 51–51. 1 indexed citations
5.
Suzuki, Yasuo, Kan Katayama, Tomohiro Murata, et al.. (2023). Mutation Analysis of Autosomal-Dominant Polycystic Kidney Disease Patients. Genes. 14(2). 443–443. 4 indexed citations
6.
Katayama, Kan, Hiroshi Matsuo, Mika Fujimoto, et al.. (2022). Mutation Analysis of Thin Basement Membrane Nephropathy. Genes. 13(10). 1779–1779. 5 indexed citations
7.
Katayama, Kan, Kei Suzuki, Shiro Nakamori, et al.. (2022). Disruption of the glomerular basement membrane associated with nutcracker syndrome and double inferior vena cava in Noonan syndrome: a case report. BMC Nephrology. 23(1). 65–65. 2 indexed citations
8.
Mano, Akiko, Takashi Nishimura, Masaaki Ishii, et al.. (2022). Usefulness of hybrid veno-arterial extracorporeal membrane oxygenation for lung ischemia–reperfusion injury after biventricular assist device implantation. Journal of Artificial Organs. 25(3). 266–269.
9.
Murata, Tomohiro, et al.. (2021). Perforation of the right atrial appendage during implantation of a leadless pacemaker. Journal of Arrhythmia. 38(1). 163–165. 2 indexed citations
10.
Katayama, Kan, Kensuke Joh, Masahiro Yamawaki, et al.. (2021). Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine. Clinical Kidney Journal. 15(3). 567–568. 8 indexed citations
11.
Katayama, Kan, Keiko Oda, Mika Fujimoto, et al.. (2021). Membranous nephropathy associated with multicentric Castleman’s disease that was successfully treated with tocilizumab: a case report and review of the literature. BMC Nephrology. 22(1). 216–216. 4 indexed citations
12.
Matsuo, Hiroshi, Kan Katayama, Aoi Hayasaki, et al.. (2021). Biliary peritonitis due to liver cyst rupture in autosomal dominant polycystic kidney disease. BMC Gastroenterology. 21(1). 267–267. 1 indexed citations
13.
Katayama, Kan, Kunihiro Asanuma, Keiko Oda, et al.. (2019). Thrombotic Microangiopathy Associated with Carbon Ion Radiotherapy and Chemotherapy for Osteosarcoma: a Case Report. SN Comprehensive Clinical Medicine. 1(9). 682–686.
14.
Oda, Keiko, Kan Katayama, Tomohiro Murata, et al.. (2018). Acute kidney injury due to thin basement membrane disease mimicking Deferasirox nephrotoxicity: a case report. BMC Nephrology. 19(1). 363–363. 3 indexed citations
15.
Suzuki, Yasuo, Kan Katayama, Eiji Ishikawa, et al.. (2017). Granulomatous interstitial nephritis due to chronic lymphocytic leukemia: a case report. BMC Nephrology. 18(1). 348–348. 6 indexed citations
16.
Kakimoto, Masaki, Takayuki Hirano, Tomohiro Murata, et al.. (2015). [Subclavian Artery Hemorrhage Related to Everolimus in a Patient with Recurrent Breast Cancer--A Case Report].. PubMed. 42(12). 1806–8. 2 indexed citations
17.
Wakabayashi, Mai, Takayasu Mori, Kiyoshi Isobe, et al.. (2013). Impaired KLHL3-Mediated Ubiquitination of WNK4 Causes Human Hypertension. Cell Reports. 3(3). 858–868. 179 indexed citations
18.
Yanoh, Kenji, Yoshiaki Norimatsu, Yasuo Hirai, et al.. (2008). New diagnostic reporting format for endometrial cytology based on cytoarchitectural criteria. Cytopathology. 20(6). 388–394. 29 indexed citations
19.
Gong, Xiangyang, S. Higano, Shunji Mugikura, et al.. (2008). Virtually Peeling Off the Skull and Scalp: A Simple Way of Mapping the Superficial Cerebral Veins on the Brain Surface. Stereotactic and Functional Neurosurgery. 86(6). 345–350. 10 indexed citations
20.
Murata, Tomohiro, et al.. (1999). Inhibition of Baroreflex Vagal Bradycardia by Selective Stimulation of Arterial Chemoreceptors in Rats. Experimental Physiology. 84(5). 897–906. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026